LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

Search

CorMedix Inc

Suletud

SektorTervishoid

12.73 3.83

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.1

Max

12.77

Põhinäitajad

By Trading Economics

Sissetulek

7.2M

21M

Müük

7.9M

39M

P/E

Sektori keskmine

47.44

56.602

Aktsiakasum

0.299

Kasumimarginaal

52.822

Töötajad

64

EBITDA

16M

14M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+43.89% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

13. aug 2025

Turustatistika

By TradingEconomics

Turukapital

168M

804M

Eelmine avamishind

8.9

Eelmine sulgemishind

12.73

Uudiste sentiment

By Acuity

50%

50%

198 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. mai 2025, 20:40 UTC

Omandamised, ülevõtmised, äriostud

FedEx Names CEO, Chairman for Planned Freight Spinoff

20. mai 2025, 00:00 UTC

Peamised uudised

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

19. mai 2025, 23:48 UTC

Market Talk

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19. mai 2025, 23:43 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

19. mai 2025, 22:33 UTC

Market Talk

Uranium Buyers Could Accelerate Restocking -- Market Talk

19. mai 2025, 22:16 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19. mai 2025, 22:16 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Sell Stake for CNY4.15B

19. mai 2025, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Sell Stake to China Resources Land

19. mai 2025, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19. mai 2025, 22:02 UTC

Tulu

Trip.com Group 1Q Rev $1.9B >TCOM

19. mai 2025, 22:02 UTC

Tulu

Trip.com Group 1Q Adj EPS 82c >TCOM

19. mai 2025, 22:02 UTC

Tulu

Trip.com Group 1Q EPS 84c >TCOM

19. mai 2025, 21:58 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

19. mai 2025, 21:58 UTC

Market Talk

Global Equities Roundup: Market Talk

19. mai 2025, 21:58 UTC

Market Talk

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19. mai 2025, 21:50 UTC

Tulu

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19. mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19. mai 2025, 20:20 UTC

Peamised uudised

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19. mai 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19. mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

19. mai 2025, 19:59 UTC

Peamised uudised

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19. mai 2025, 19:58 UTC

Market Talk

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19. mai 2025, 19:52 UTC

Market Talk

Imports Accelerate at Southern California Ports -- Market Talk

19. mai 2025, 19:16 UTC

Market Talk

Oil Futures Edge Up After Shaky Start -- Market Talk

19. mai 2025, 19:00 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Sanmina Shares Fall After Deal to Buy AMD's Newly Acquired Manufacturing Company

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

43.89% tõus

12 kuu keskmine prognoos

Keskmine 17.67 USD  43.89%

Kõrge 20 USD

Madal 13 USD

Põhineb 6 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

6

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

198 / 382 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.